Related Experiment Video

Updated: Jul 9, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

[Ocular manifestations during hepatitis C infection]

Marta Misiuk-Hojło1, Magdalena Michałowska, Iwona Banach

  • 1Katedra i Klinika Okulistyki Akademii Medycznej we Wrocławiu.

Przeglad Epidemiologiczny
|December 12, 2007
PubMed

Insights

Hepatitis C virus (HCV) infection can manifest with various eye conditions, from dry eye to vision-threatening complications like ischemic retinopathy. Early detection of these ophthalmic symptoms is crucial for managing HCV.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Hepatology

Context:

  • Hepatitis C virus (HCV) is a significant global blood-borne pathogen.
  • Easy transmission, asymptomatic periods, and lack of routine screening complicate HCV detection.
  • Limited prophylaxis and high treatment costs necessitate increased awareness.

Purpose:

  • To highlight the diverse ophthalmic manifestations associated with Hepatitis C virus infection.
  • To emphasize the importance of recognizing ocular symptoms as potential indicators of HCV.
  • To underscore the need for broader knowledge dissemination regarding HCV and its systemic effects.

Summary:

  • HCV infection presents with a spectrum of ocular symptoms, including keratoconjunctivitis sicca (dry eye).
  • More severe ophthalmic complications include ischemic retinopathy, macular edema, and ischemic neuropathy.
  • These eye conditions can serve as crucial indicators for diagnosing HCV, especially in asymptomatic individuals.

Impact:

  • Increased awareness among clinicians regarding HCV-related ophthalmic conditions can lead to earlier diagnosis and intervention.
  • Recognizing these symptoms may improve patient outcomes by facilitating timely HCV treatment.
  • Enhanced understanding of HCV's systemic impact can contribute to public health strategies for disease control.

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...